164 related articles for article (PubMed ID: 6824568)
1. Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems.
Silvestrini B; Hahn GM; Cioli V; De Martino C
Br J Cancer; 1983 Feb; 47(2):221-31. PubMed ID: 6824568
[TBL] [Abstract][Full Text] [Related]
2. Lonidamine, a new approach to cancer therapy.
Caputo A; Silvestrini B
Oncology; 1984; 41 Suppl 1():2-6. PubMed ID: 6371644
[TBL] [Abstract][Full Text] [Related]
3. Lonidamine: a hyperthermic sensitizer of HeLa cells in culture and of the Meth-A tumor in vivo.
Kim JH; Kim SH; Alfieri A; Young CW; Silvestrini B
Oncology; 1984; 41 Suppl 1():30-5. PubMed ID: 6717892
[TBL] [Abstract][Full Text] [Related]
4. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells.
Floridi A; Paggi MG; D'Atri S; De Martino C; Marcante ML; Silvestrini B; Caputo A
Cancer Res; 1981 Nov; 41(11 Pt 1):4661-6. PubMed ID: 7306982
[TBL] [Abstract][Full Text] [Related]
5. Cell membrane changes induced by lonidamine in human erythrocytes and T lymphocytes, and Ehrlich ascites tumor cells.
De Martino C; Malorni W; Accinni L; Rosati F; Nista A; Formisano G; Silvestrini B; Arancia G
Exp Mol Pathol; 1987 Feb; 46(1):15-30. PubMed ID: 3492392
[TBL] [Abstract][Full Text] [Related]
6. The effect of gossypol and Lonidamine on electron transport in Ehrlich ascites tumor mitochondria.
Floridi A; D'Atri S; Bellocci M; Marcante ML; Paggi MG; Silvestrini B; Caputo A; De Martino C
Exp Mol Pathol; 1984 Apr; 40(2):246-61. PubMed ID: 6705894
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the recovery from potentially lethal damage by lonidamine.
Hahn GM; van Kersen I; Silvestrini B
Br J Cancer; 1984 Nov; 50(5):657-60. PubMed ID: 6208924
[TBL] [Abstract][Full Text] [Related]
8. Lonidamine can enhance the cytotoxic effect of cisplatin in human tumour cells and rodent cells.
Raaphorst GP; Feeley MM; Heller DP; Danjoux CE; Martin L; Maroun JA; De Sanctis AJ
Anticancer Res; 1990; 10(4):923-7. PubMed ID: 2382989
[TBL] [Abstract][Full Text] [Related]
9. Modification of tumor cell sensitivity to antineoplastic agents lonidamine and bouvardin (NSC 259968) at elevated temperatures.
Adwankar MK; Chitnis MP
Neoplasma; 1986; 33(2):217-23. PubMed ID: 3713924
[TBL] [Abstract][Full Text] [Related]
10. Effects of Lonidamine on murine and human tumor cells in vitro. A morphological and biochemical study.
De Martino C; Battelli T; Paggi MG; Nista A; Marcante ML; D'Atri S; Malorni W; Gallo M; Floridi A
Oncology; 1984; 41 Suppl 1():15-29. PubMed ID: 6717891
[TBL] [Abstract][Full Text] [Related]
11. Morphological damage induced in vivo by Lonidamine on human metastatic cancer cells.
De Martino C; Battelli T; Cavaliere R; Gallo Curcio C; Bellocci M; Manocchi D; Giustini L; Mattioli R; Rinaldi M; Di Filippo F
Oncology; 1984; 41 Suppl 1():94-103. PubMed ID: 6717904
[TBL] [Abstract][Full Text] [Related]
12. Influence of 5-hydroxytryptamine on the combination effect of lonidamine or gossypol and hyperthermia on Ehrlich tumour in vivo.
Molla MR; Yoshiga K; Takada K
Anticancer Res; 1987; 7(3 Pt B):361-4. PubMed ID: 3631888
[TBL] [Abstract][Full Text] [Related]
13. Action of the antitumor and antispermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria.
Floridi A; Lehninger AL
Arch Biochem Biophys; 1983 Oct; 226(1):73-83. PubMed ID: 6227286
[TBL] [Abstract][Full Text] [Related]
14. The effect of the drug lonidamine on Chinese hamster ovary cells in vitro and on experimental tumors.
Rotin D; Tannock IF
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1595-8. PubMed ID: 6480446
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial of lonidamine with whole body hyperthermia in advanced cancer.
Robins HI; Longo WL; Lagoni RK; Neville AJ; Hugander A; Schmitt CL; Riggs C
Cancer Res; 1988 Nov; 48(22):6587-92. PubMed ID: 3180069
[TBL] [Abstract][Full Text] [Related]
16. The combined use of radiation therapy and lonidamine in the treatment of brain metastases.
DeAngelis LM; Currie VE; Kim JH; Krol G; O'Hehir MA; Farag FM; Young CW; Posner JB
J Neurooncol; 1989 Sep; 7(3):241-7. PubMed ID: 2677257
[TBL] [Abstract][Full Text] [Related]
17. Phase II evaluation of Lonidamine in patients with advanced malignancy.
Evans WK; Shepherd FA; Mullis B
Oncology; 1984; 41 Suppl 1():69-77. PubMed ID: 6717899
[TBL] [Abstract][Full Text] [Related]
18. Morphological effects of lonidamine on two human-tumor cell culture lines.
Szekely JG; Lobreau AU; Delaney S; Raaphorst GP; Feeley M
Scanning Microsc; 1989 Jun; 3(2):681-91; discussion 691-3. PubMed ID: 2814409
[TBL] [Abstract][Full Text] [Related]
19. Thermal behavior of a human glioma cell line and its response to combinations of hyperthermia and lonidamine.
Floridi A; Gentile FP; Bruno T; Delpino A; Iacobini C; Paggi MG; Castiglione S; Benassi M
Oncol Res; 1993; 5(1):1-10. PubMed ID: 8369571
[TBL] [Abstract][Full Text] [Related]
20. Effect of lonidamine on protein synthesis in neoplastic cells.
Floridi A; Delpino A; Nista A; Feriozzi R; Marcante ML; Silvestrini B; Caputo A
Exp Mol Pathol; 1985 Jun; 42(3):293-305. PubMed ID: 3996552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
